Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Siegfried
Siegfried
Activities:
Manufacturing
Ingredients
Regulatory
Research & Development
Cleaning
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Swiss biomanufacturing sector continues to thrive in 2023
Seigfried, Lonza, ten23 health, Bachem and Dottikon all announce major expansions
Manufacturing
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
Siegfried has made a total investment for the majority acquisition of CDMO DiNAMIQS and the establishment of the new GMP facility that will be in the mid-double-digit millions Swiss Francs
You need to be a subscriber to read this article.
Click here
to find out more.
Manufacturing
Optimising scale-up with flow process technologies
Speed of synthesis is of the essence when medicinal chemists invent new molecules, reports Sarah Houlton
Design & Build
Siegfried acquires three BASF sites
Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
Media
Siegfried Group sells biologics division
<p>The Siegfried Group, based in Zofingen in Switzerland, is selling its biotechnology business unit to an Indian company, Avesta Biotherapeutics and Research (ABRPL), for an undisclosed sum. </p>
Sharp increase in profits at Siegfried Group
Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.
Subscribe now